Jiang, S., Morris, T., Forster, M. D., Thistlethwaite, F., Tuthill, M. H., Williams, A., Finch, W. (2026). Phase Ib evaluation of a recombinant overlapping peptide survivin immunotherapy: Safety, immunogenicity, and immune–clinical associations in advanced solid tumours.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2651